Evidence-Based Medicine Guidelines
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Folic Acid and Folinic Acid for Reducing Side Effects in Patients Receiving Methotrexate for Rheumatoid Arthritis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455343/all/Folic_acid_and_folinic_acid_for_reducing_side_effects_in_patients_receiving_methotrexate_for_rheumatoid_arthritis.
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455343/all/Folic_acid_and_folinic_acid_for_reducing_side_effects_in_patients_receiving_methotrexate_for_rheumatoid_arthritis. Accessed March 24, 2023.
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455343/all/Folic_acid_and_folinic_acid_for_reducing_side_effects_in_patients_receiving_methotrexate_for_rheumatoid_arthritis
Folic Acid and Folinic Acid for Reducing Side Effects in Patients Receiving Methotrexate for Rheumatoid Arthritis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455343/all/Folic_acid_and_folinic_acid_for_reducing_side_effects_in_patients_receiving_methotrexate_for_rheumatoid_arthritis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
ID - 455343
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455343/all/Folic_acid_and_folinic_acid_for_reducing_side_effects_in_patients_receiving_methotrexate_for_rheumatoid_arthritis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
